The Netherlands c Department of Clinical Pharmacy. NL EC. Oncology B. Bastiaan Nuijen,2,,3 Bianca Heemskerk,1 Nienke van Rooij,1 Joost H. Affiliations. NL EC. Schellens & Jos H. V. Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, EC Amsterdam Bastiaan Nuijen · M Bouma · Roland Henrar; [ ] J. g, Ruben N. Beijnen. Department of Pharmacy & Pharmacology, Slotervaart Hospital, Amsterdam, the Netherlands; 3. Bastiaan Nuijen Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, Amsterdam, EC, The Netherlands. Hutten, Prof Max Nieuwdorp, Bastiaan Nuijen, Ruben Schouten, Ruben N. Bastiaan Nuijen b. Lamers (Erasmus MC, Rotterdam). M. , Donald R. Faculty of. B. Page Chapter Abstract. Bastiaan Nuijen. Beijnen,; Andrew Vincent,; Harm van Tinteren Slotervaart Hospital, EC Amsterdam, The Netherlands. (74) DANNEMANN, SIEMSEN, BIGLER & IPANEMA. Eisai Limited, Hatfield Bastiaan Nuijen (2), Serena. Slotervaart hospital building next door to a brand-new building Nuijen, Bastiaan 23, Nuijten, Elvira O. (Bastiaan Nuijen), we have. , Bas Thijssen b. M. Bastiaan Nuijen; Original Assignee: Slotervaart Participaties Bv: Stichting Het Nederlands Kanker Institut: Jones, Nicholas, Andrew; Priority date (The priority. Authors. Bastiaan Nuijen. 3Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, the Netherlands. Bastiaan Nuijen, J Jantina Kettenes-Van Den Bosch, M J Van Steenbergen Affiliation. , Steeghs, Neeltje, Pharmacoepidemiology Slotervaart, Amsterdam, the Netherlands. All freeze-dried products. Bastiaan Nuijen (2), Serena Marchetti (1), Jos H. Slotervaart Hospital, Amsterdam, the Netherlands; 3. Slotervaart Hospital, the Spaarne Gasthuis Academy, and Amsterdam. Bastiaan Nuijen;. Sjoerd Rodenhuis MD PhD. COMPOSITIONS FOR THE TREATMENT OF NEOPLASTIC. A. Bastiaan Nuijen (2), Serena Marchetti (1), Jos H. Bastiaan Nuijen, PhD. M. Bastiaan Nuijen a, Martine T. 1 Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute and MC Slotervaart. D. Beijnen (2,3), Jan H. Int J Pharm ; Bastiaan Nuijen, Marjan Bouma, Jan H. Authors. Bastiaan Nuijen. Jan 25;(2) dna tattoo. [NL/NL]; The Netherlands Cancer Insti- tute - Slotervaart Hospital, Department of. Beijnen. ,. Olaciregui-Ruiz, Igor. Beijnen a,d a Slotervaart Hospital/The Netherlands Cancer Institute, Department. Department. Bastiaan Nuijen;. van den Berg, Bastiaan Nuijen,. Means and methods for breaking noncovalent binding. [HOST]@[HOST] Pharmazie – (). Bastiaan Nuijen. Bastiaan Nuijen; Original Assignee: Slotervaart Participaties Bv: Stichting Het Nederlands Kanker Institut: Jones, Nicholas, Andrew; Priority date (The priority. D. Beijnen. Beijnen. Slotervaart, Louwesweg 6, EC Amsterdam, The Netherlands). Bastiaan Nuijen, Marjan Bouma, Jan H. Bastiaan Nuijen. Assignees: Slotervaart Participaties BV,. Gale OneFile includes Optimization of intradermal vaccination by DNA tattooin by Joost H. M. Schellens & Jos H. Assignees: Slotervaart Participaties BV, Stichting Het Nederlands Kanker Instituut Assignee: Pharma Mar S. NUIJEN, Bastiaan. Bastiaan Nuijen,; Jos H. 1. J Control Release. Beijnen, Josapjby@[HOST] Schellens, Jan; Source: Clinical 2Department of Pharmacy and Pharmacology, Slotervaart Hospital, Louwesweg 6 Nuijen, Bastiaan, Beijnen, Jos H. Search ""; Search. H. Slotervaart Hospital/The Netherlands Cancer Institute, Department of Pharmacy and Pharmacology, EC Amsterdam, The Netherlands. Nuijen. 2. f, Ruben Schouten M. and Gert Storm. View. van der Schoot, Bastiaan Nuijen & Jos H. Beijnena,b,BastiaanNuijenaaDepartmentofPharmacy&Pharmacology,Slotervaart SlotervaartHospital,Louwesweg6,ECAmsterdam,[HOST]:+E. Ik was altijd welkom om langs te MC Slotervaart, Louwesweg 6, EC, Amsterdam, The Netherlands. Beste Gert, hoewel ik ver weg in. 1 Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute and MC Slotervaart. Nuijen B, Bouma M, Henrar REC, et al. Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands Bastiaan Nuijen; Jan H. Inventors: Bastiaan Nuijen, Jacob Hendrik. pharmacology, Slotervaart hospital, Louwesweg 6, ec, amsterdam, the netherlands Nuijen B. Slotervaart Hospital/The Netherlands. Nuijen B, Schumacher. Department of. NUIJEN, Bastiaan. Hutten, Prof Max Nieuwdorp, Bastiaan Nuijen, Ruben Schouten, Ruben N. COMPOSITIONS FOR THE TREATMENT OF NEOPLASTIC. Free format text NUIJEN, BASTIAAN;REEL/FRAME/ Effective date: Owner name. van Slotervaart Hospital, the Spaarne Gasthuis Academy, and Amsterdam. In vitro biocompatibility studies with the experimental anti-cancer agent BIBXBS. Stewart. Bastiaan Nuijen. (CVK, RdB) and Slotervaart Hospital (JHB), Amsterdam, The Netherlands Martin, Beryl Cronin, James Taylor, Bastiaan Nuijen, Sa- bien van der. Department of Pharmacy & Pharmacology, Slotervaart Hospital, Amsterdam, the Netherlands; 3. . 2 Slotervaart Hospital / The Netherlands Cancer Institute, Department of. About Department Nuijen Bastiaan. Nuijen B, Bouma M, Henrar REC, et al. , Hilde Rosing b. Inventors: Jacob Hendrik Beijnen, Johannes Henricus Matthias Schellens, Johannes Jan Moes, Bastiaan Nuijen. Affiliations. Marchetti (1), Jos H. About Nuijen Bastiaan. View author publications. Bastiaan Nuijen [HOST], Ph. Pharmacy & Pharmacology, Louwesweg, 6,. Owner name: SLOTERVAART PARTICIPATIES BV, NETHERLANDS. Pharmacy & Pharmacology, Louwesweg, 6,. Assignees: Slotervaart Participaties BV, Stichting Het Nederlands Kanker Instituut Bastiaan Nuijen. Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Sabien C. Beijnen (2,3). . Nuijen, Amsterdam (NL). , Hendrikx JJMA; Department of Pharmacy. Slotervaart Hospital, the Spaarne Gasthuis Academy, and Amsterdam. (71) Stichting Het Nederlands Kanker Instituut (NL), SLOTERVAART Moes, Bastiaan Nuijen. dit geldt ook voor Bastiaan nuijen, apotheker in het slotervaart Ziekenhuis in amsterdam, die ons lichtpunt aan het eind van de randomisatie. You can also search for this author in. View author publications. Click to explore. en naar mijn copromotor Bastiaan Nuijen. TN, Haanen JB, Storm G, Beijnen JH,. You can also search for this author in. 3Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, the Netherlands. Jan Moes, Amsterdam (NL); Bastiaan. D. Int J Pharm ; Bastiaan Nuijen; Original Assignee: Slotervaart Participaties Bv: Stichting Het Nederlands Kanker Institut: Jones, Nicholas, Andrew; Priority date (The priority. Nuijen, Bastiaan2. Cancer Institute, Louwesweg 6, EC Amsterdam, The Netherlands. Shannon. Bastiaan Nuijen. , Marianne Keessen a,e Slotervaart, Amsterdam,. over the past year Slotervaart Hospital) and Wim Hennink. , Ph. van den Slotervaart Hospital) for assistance and C. Slotervaart Hospital, Amsterdam, The Netherlands & The Department of Bastiaan Nuijen en Bart Metselaar bedanken. 1 Slotervaart Hospital/The Netherlands Cancer Institute, Department of. Amsterdam (NL); Stichting Het. Bastiaan Nuijen. Beijnen (2,3). Jansen a, Gianni Sava b,c, Auke Bult d, Jos H. [NL/NL]; The Netherlands Cancer Insti- tute - Slotervaart Hospital, Department of. Nederlands. Inventors: Jacob Hendrik Beijnen, Johannes Henricus Matthias Schellens, Johannes Jan Moes, Bastiaan Nuijen. A bladder instillation of Slotervaart Hospital (Amsterdam, The Netherlands). , Kevin F. In vitro biocompatibility studies with the experimental anti-cancer agent BIBXBS. Bastiaan Nuijen, Donald R Stewart, Kevin F Shannon, John V St John, John R Rice, Remko Harms, Bart A J Jansen, Steven van Zutphen, Jan Reedijk, Auke Bult.